These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20956182)

  • 1. Mucoactive therapy in COPD.
    Decramer M; Janssens W
    Eur Respir Rev; 2010 Jun; 19(116):134-40. PubMed ID: 20956182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Chong J; Cates CJ
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoactive drugs.
    Balsamo R; Lanata L; Egan CG
    Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN
    Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN; Cates CJ
    Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
    Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
    Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoactive drugs for asthma and COPD: any place in therapy?
    Rogers DF
    Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001287. PubMed ID: 16855965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoactive drugs and multiple applications in pulmonary disease therapy.
    Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
    Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical issues of mucus accumulation in COPD.
    Ramos FL; Krahnke JS; Kim V
    Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Normansell R; Maisey S; Poole P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion.
    Chakravorty I; Chahal K; Austin G
    Int J Chron Obstruct Pulmon Dis; 2011; 6():693-9. PubMed ID: 22259246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J; Karner C; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.